| Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells HM Brechbuhl, K Vinod‐Paul, AE Gillen, EG Kopin, K Gibney, AD Elias, ... Molecular carcinogenesis 59 (10), 1129-1139, 2020 | 37 | 2020 |
| New generation breast cancer cell lines developed from patient-derived xenografts J Finlay-Schultz, BM Jacobsen, D Riley, KV Paul, S Turner, ... Breast Cancer Research 22, 1-12, 2020 | 36 | 2020 |
| Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer CAL Amy R. Dwyer, Thu H. Truong, Carlos Perez Kerkvliet, Kiran V. Paul ... British Journal of Cancer, 2020 | 30* | 2020 |
| Cytokeratin 5 alters β-catenin dynamics in breast cancer cells O McGinn, AV Ward, LM Fettig, D Riley, J Ivie, KV Paul, P Kabos, ... Oncogene 39 (12), 2478-2492, 2020 | 26 | 2020 |
| Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2) S Karmakar, O Ramirez, KV Paul, AK Gupta, V Kumari, V Botti, ... NAR cancer 4 (2), zcac015, 2022 | 13 | 2022 |
| Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1) AK Gupta, T Murthy, KV Paul, O Ramirez, JB Fisher, S Rao, ... Nucleic acids research 47 (2), 970-980, 2019 | 13 | 2019 |
| Estrogens and progestins cooperatively shift breast cancer cell metabolism AV Ward, SB Matthews, LM Fettig, D Riley, J Finlay-Schultz, KV Paul, ... Cancers 14 (7), 1776, 2022 | 7 | 2022 |
| Cytokeratins 5 and 17 maintain an aggressive epithelial state in basal-like breast cancer O McGinn, D Riley, J Finlay-Schultz, KV Paul, P Kabos, CA Sartorius Molecular Cancer Research 20 (9), 1443-1455, 2022 | 5 | 2022 |
| Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor-positive breast cancer PK Heather M. Brechbuhl, Mengyu Xie, Etana G. Kopin, Amy L. Han, Kiran Vinod ... Molecular Carcinogenesis, 2021 | 5* | 2021 |
| The Development and Use of Scalable Systems for Studying Aberrant Splicing in SF3B1-Mutant CLL T Murthy, KV Paul, AC Minella, P Manoj M Chronic Lymphocytic Leukemia 1881, 83-99, 2018 | 3 | 2018 |
| Obesity-driven changes in breast tissue exhibit a pro-angiogenic extracellular matrix signature EE Bamberg, M Maslanka, K Vinod-Paul, S Sams, E Pollack, M Conklin, ... Matrix Biology Plus 24, 100162, 2024 | | 2024 |
| Estradiol (E2) concentration shapes the chromatin binding landscape of the estrogen receptor AL Han, K Vinod-Paul, S Rao, HM Brechbuhl, CA Sartorius, ... bioRxiv, 2022.09. 23.509212, 2022 | | 2022 |
| Cover Image, Volume 61, Issue 3 HM Brechbuhl, M Xie, EG Kopin, AL Han, K Vinod‐Paul, J Hagen, ... Molecular Carcinogenesis 61 (3), i-i, 2022 | | 2022 |
| Cytokeratin 5 promotes endocytosis to remodel cell adhesions in breast cancer OF McGinn, AV Ward, J Finlay-Schultz, KV Paul, P Kabos, C Sartorius Cancer Research 80 (16_Supplement), 2605-2605, 2020 | | 2020 |
| New generation breast cancer cell lines developed from patient-derived xenografts CAS Jessica Finlay-Schultz , Britta M Jacobsen , Duncan Riley , Kiran V Paul ... Breast cancer reasearch, 2020 | | 2020 |
| Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore A Chaudhuri, R Gupta, P Shah, M Manoharan, KV Paul, R Goupta US Patent App. 16/329,720, 2019 | | 2019 |
| Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore A Chaudhuri, R Gupta, S Priyanka, M MONOHARAN, R Gupta US Patent US10350280B2, 2018 | | 2018 |
| Neo-epitope detection and immune infiltrate analysis of colorectal cancer samples FY Lo, N Mandloi, T Yeatman, K Paul, A Patil, S Anderson, R Gupta, ... Cancer Research 77 (13_Supplement), 413-413, 2017 | | 2017 |
| A novel algorithm to identify TCR-binding somatic mutations from human cancers P Shah, KV Paul, M Manoharan, A Chaudhuri, R Gupta Cancer Research 77 (13_Supplement), 3579-3579, 2017 | | 2017 |
| Analysis of tumor microenvironment identifies pathways predicting response to checkpoint control inhibitors: A case study comparing the immune microenvironment of uveal … R Gupta, N Mandloi, A Patil, M Manoharan, R Sathian, KV Paul, ... CANCER IMMUNOLOGY RESEARCH 4 (11), 2016 | | 2016 |
